Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Operating Cash Flow Growth
-5.58%
TTM · Period ending:
LCTX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-5.58%period ending
Latest reported-5.58%period ending
LCTX TTM Cash from Operations YoY % (-40.00% → -5.58%)
Year-over-year change
High-resolution chart · PNG
LCTX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 17.1088% | |
| 10.8886% | |
| -10.5151% | |
| -23.1036% | |
| 3.4996% | |
| -4.1919% | |
| 6.5217% | |
| -9.0909% | |
| -58.6207% | |
| -170.5882% | |
| -238.4615% | |
| -20.8333% | |
| -14.2857% | |
| 19.0476% | |
| 0% | |
| -16.6667% | |
| -25% | |
| -57.1429% | |
| -42.8571% | |
| -38.4615% | |
| -23.0769% | |
| -40% |